Ottawa urged to halt imports of endangered monkeys for drug testing, amid U.S. probe
TORONTO — The federal government is facing mounting pressure to investigate the importation of endangered monkeys for medical research in Quebec, after a United States probe allegedly prompted a pharmaceutical giant to sharply increase its imports north of the border.
The influx of long-tailed macaques from Cambodia, which the U.S. alleges are being illegally captured from the wild, has animal advocates, researchers and opposition politicians sounding the alarm over animal welfare and potential public-health risks.
The latest push comes from the federal NDP, which is urging Ottawa to bring “immediate attention” to the issue.
Investigators in the U.S. attorney’s office in the Southern District of Florida indicted eight people in November 2022, including two senior Cambodian officials, over what they described as “multiple felonies for their role in bringing wild long-tailed macaques into the United States.” No charges have been brought against the company or any of its officials and the company has said it will fully co-operate with the U.S. investigation.